跳至主要内容
临床试验/NCT01542099
NCT01542099已完成不适用

The Effect Site Concentration of Remifentanil Blunting Hemodynamic Responses to Tracheal Intubation: Single Versus Double Lumen Tube

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2011年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
Changes from baseline in heart rate and mean arterial pressure after intubation

研究概览

简要总结

The purpose of this study is to evaluate the effect site concentration of remifentanil blunting hemodynamic changes to tracheal intubation of single or double lumen tubes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing thoracic surgery that require one lung ventilation

排除标准

  • patient who does not agree with this study
  • BMI < 16.0 or BMI > 30
  • cardiovascular disease, pulmonary disease, renal disease
  • alcoholic abuser or drug abuser
  • patient who takes any drug to influence cardiovascular system or sympathetic nervous system
  • any use of local anesthetics or drugs to influence cardiovascular system during tracheal intubation

研究组 & 干预措施

Single lumen tube

Active Comparator

Single lumen tube intubation during remifentanil infusion

干预措施: Remifentanil (Drug)

Double lumen tube

Active Comparator

Double lumen tube intubation during remifentanil infusion

干预措施: Remifentanil (Drug)

结局指标

主要结局

Changes from baseline in heart rate and mean arterial pressure after intubation

时间窗: intubation period

Heart rate and mean arterial pressure will be recorded at 2 minutes before intubation, 1 minute before intubation, during intubation, 1 minute after intubation. The mean value of heart rate and mean arterial pressure before intubation will be regarded as the baseline values. If maximum heart rate or mean arterial pressure after intubation increased by \>15% from baseline value, the response will be regarded as "fail" and increased concentration of remifentanil will be applied to next patient by up and down sequential method.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jae-Hyon Bahk, MD, PhD

professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验